Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MYCN amplification by differential PCR

S N Huddart1, J R Mann, A G McGukin

  • 1Department of Oncology, Children's Hospital, Birmingham, United Kingdom.

Pediatric Hematology and Oncology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas.

Nature communications·2021
Same author

Motion Artifacts and Correction in Multipulse High-Frame Rate Contrast-Enhanced Ultrasound.

IEEE transactions on ultrasonics, ferroelectrics, and frequency control·2018
Same author

Factors associated with ambulatory care sensitive emergency department visits for South Carolina Medicaid members with intellectual disability.

Journal of intellectual disability research : JIDR·2017
Same author

Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer.

Oncogene·2014
Same author

Use of state administrative data sources to study adolescents and young adults with rare conditions.

Journal of general internal medicine·2014
Same author

Failure to confirm abnormal copper utilization in crinkler (cr) mice.

Biological trace element research·2013
Same journal

Early discharge for low-risk pediatric febrile neutropenia: safe only in selected centers.

Pediatric hematology and oncology·2026
Same journal

Clinical and microbiological characteristics of viridans group streptococcal bacteremia in pediatric and adolescent patients with cancer.

Pediatric hematology and oncology·2026
Same journal

Parental and Patients' Awareness, Knowledge, and Willingness for Human Papillomavirus Vaccination Among Survivors of Childhood Hematologic Malignancies.

Pediatric hematology and oncology·2026
Same journal

How we Investigate Bone Marrow Failure Syndromes in Pediatric Patients.

Pediatric hematology and oncology·2026
Same journal

Prepubertal Initiation of Imatinib is Associated with Reduced Final Height in Children with Chronic Myeloid Leukemia.

Pediatric hematology and oncology·2026
Same journal

Feasibility and Validity of the 6-Minute Cycling Test in Childhood Cancer Patients.

Pediatric hematology and oncology·2026
See all related articles

A new differential polymerase chain reaction (PCR) method quickly estimates MYCN oncogene amplification in neuroblastoma. This technique uses less DNA and avoids radioactivity, enabling analysis of small biopsy samples and archival material.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neuroblastoma is a pediatric cancer often associated with MYCN oncogene amplification.
  • Accurate MYCN amplification status is crucial for prognosis and treatment decisions.
  • Conventional methods like Southern blotting are time-consuming and require significant DNA input.

Purpose of the Study:

  • To develop and present a novel, rapid method for quantifying MYCN oncogene amplification in neuroblastoma.
  • To offer an alternative to traditional Southern blotting techniques.
  • To enable MYCN analysis from limited clinical samples.

Main Methods:

  • Differential polymerase chain reaction (PCR) was employed to detect and quantify MYCN amplification.
  • The method was optimized for speed and reduced DNA input requirements.

Related Experiment Videos

  • Comparison with conventional Southern blotting was performed.

    • Main Results:

    • The differential PCR technique demonstrated faster results compared to Southern blotting.
    • The method successfully quantified MYCN amplification using smaller amounts of tumor DNA.
    • No radioactive materials were required for the differential PCR assay.

    Conclusions:

    • Differential PCR provides a rapid, sensitive, and non-radioactive method for assessing MYCN amplification in neuroblastoma.
    • This technique facilitates the analysis of limited biopsy samples and archival paraffin-embedded tissues.
    • The method holds potential for improved diagnostic capabilities and retrospective studies in neuroblastoma research.